You can't buy ElevenLabs stock, shares, or equity on public markets or most brokerages — ElevenLabs is a private company valued at approximately $19.6B. On SOAR you can trade synthetic prediction markets on ElevenLabs's valuation, not real equity.
AI voice technology company offering realistic text-to-speech and voice cloning.
| Indicative valuation | $19.6B |
|---|---|
| SOAR ticker | $ELVN |
ElevenLabs is privately held, so its shares and equity aren't listed on public stock exchanges or available through most brokerage accounts. SOAR doesn't sell ElevenLabs equity — instead you can take a position on ElevenLabs's valuation through synthetic prediction markets.
Direct pre-IPO equity in ElevenLabs is typically limited to employees and accredited investors trading on private secondary markets. On SOAR, anyone on the waitlist can get exposure to ElevenLabs's valuation (most recently around $19.6B) through synthetic markets — without buying or holding real shares.
Meet Eliane and Alberto. Eliane lost her voice in childhood and Alberto lost his sight at 46. The two met in São Paulo in 2024, found their own way to communicate, and ultimately fell in love. We worked with Eliane to give her a voice that sounds like her family. For the first https://t.co/Px38ExfJeZ
We’re working with @Genesys to help enterprises deploy natural-sounding voice agents. Add ElevenAgents into your customer journey, alongside Genesys Cloud Agentic Virtual Agents, and coordinate how the agents work together. Or give Genesys agents one of our expressive, https://t.co/Z49AvsYxFQ
AI voice-cloning startup ElevenLabs says it's making more money from businesses than consumers https://t.co/X6BgJ1Bh3S
Today, we’re appointing @ashleyekramer as Chief Revenue Officer of @ElevenLabs. Ashley will work closely with our customers around the world to deploy AI that interacts naturally in their country and context. https://t.co/gnKxq9Wzta
Long $ELVN !!!
